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No enteric neurons or glia develop in the gut below the rostral foregut in mice lacking glial cell line-derived
neurotrophic factor (GDNF) or Ret. We analyzed the nature and age dependence of the effects of GDNF and, for
comparison, those of NT-3, on the in vitro development of the precursors of enteric neurons and glia. Positive and
negative immunoselection with antibodies to p75NTR were used to isolate crest-derived and crest-depleted populations
of cells from the fetal rat bowel at E12, 14, and 16. Cells were typed immunocytochemically. GDNF stimulated the
proliferation of nestin-expressing precursor cells isolated at E12, but not at E14 –16. GDNF promoted the development
of peripherin-expressing neurons (E12 @ E14 –16) and expression of TrkC. GDNF inhibited expression of S-100-
expressing glia at E14 –16. NT-3 did not affect cells isolated at E12, never stimulated precursors to proliferate, and
promoted glial as well as neuronal development at E14 –16. GFRa-1 was expressed both by crest- and non-crest-derived
cells, although only crest-derived cells anchored GFRa-1 and GFRa-2 (GFRa-1 @ GFRa-2). GDNF increased the
number of neurons anchoring GFRa-1. GFRa-1 is immunocytochemically detectable in neurons of the E13 intestine
and persists in adult neurons of both plexuses. We suggest that GDNF stimulates the proliferation of an early (E12)
NT-3-insensitive precursor common to enteric neurons and glia; by E14, this common precursor is replaced by specified
NT-3-responsive neuronal and glial progenitors. GDNF exerts a neurotrophic, but not a mitogenic, effect on the
neuronal progenitor. The glial progenitor is not maintained by GDNF. © 1998 Academic Press
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INTRODUCTION
The enteric nervous system (ENS) is formed by precur-
sor cells that migrate to the bowel from three regions of
the neural crest (Gershon, 1997). The vagal crest is the
only level that provides precursors to the entire bowel
(Epstein et al., 1994; Le Douarin et al., 1975; Le Douarin
and Teillet, 1973; Yntema and Hammond, 1954, 1955).
The sacral crest colonizes only the postumbilical gut (Le
Douarin et al., 1975; Le Douarin and Teillet, 1973;
Pomeranz and Gershon, 1990; Pomeranz et al., 1991;
Serbedzija et al., 1991), while the rostral truncal crest
provides precursors only to the esophagus and adjoining
region of the stomach (Durbec et al., 1996). Many, but
probably not all (Henion and Weston, 1997; Lo and
Anderson, 1995), crest-derived progenitors of enteric neu-
rons are multipotent when they arrive in the bowel (Lo
and Anderson, 1995; Rothman et al., 1990, 1993b;
Sextier-Sainte-Claire Deville et al., 1994). Whether or not
enteric crest-derived progenitors are multipotent, their
fate depends on factors they encounter within the enteric
microenvironment. These factors may influence the phe-
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notypic choice of multipotent precursors and the
development/survival of those progenitors that are fate-
restricted.
The developmental potential of enteric crest-derived cells
diminishes as a function of age and the cells become sorted
into multiple lineages (Blaugrund et al., 1996). Factors that
are present in the fetal bowel and have been found to
promote the development of enteric neurons include
growth factors, such as neurotrophin-3 (NT-3) (Chalazonitis
et al., 1994) and the neuropoietic cytokines, ciliary neuro-
trophic factor (CNTF) and leukemia inhibitory factor (LIF)
(Chalazonitis et al., 1998), and extracellular matrix pro-
teins, such as laminin-1 (Chalazonitis et al., 1997b; Pomer-
anz et al., 1993). An ENS exists in mice with targeted
mutation in genes encoding NT-3 (Farin˜as et al., 1994), its
high affinity receptor, TrkC (Klein et al., 1994), CNTF
(Masu et al., 1993; Takahashi et al., 1994), LIF (Sendtner et
al., 1996), or the a (CNTFRa) and b (LIFRb) components of
the tripartite neuropoietic cytokine receptor (DeChiara et
al., 1995; Gershon, 1997; Li et al., 1995). Some of these
animals (those with mutations in CNTFRa and LIFRb) lack
subsets of enteric neurons that are critical for life; never-
theless, the presence of an ENS in all of these knockout
animals establishes that neither NT-3, nor a ligand for the
neuropoietic cytokine receptor, are essential for the devel-
opment of the entire complement of enteric neurons and
glia.
In contrast to NT-3 and the neuropoietic cytokines, glial
cell line-derived neurotrophic factor (GDNF) appears to be
essential for the development of all enteric neurons and glia
below the esophagus and proximal stomach. Except for the
neurons of the presumptive esophagus and stomach, which
are derived from the rostral truncal crest (Durbec et al.,
1996), enteric neurons and glia are completely missing in
animals that lack either the receptor tyrosine kinase, Ret
(Schuchardt et al., 1994), or GDNF (Moore et al., 1996;
Pichel et al., 1996; Se´nchez et al., 1996). Ret, which is
expressed by crest-derived cells in the fetal bowel (Lo and
Anderson, 1995; Pachnis et al., 1993), is the signaling
receptor that is responsible for mediating the effects of
GDNF (Jing et al., 1996; Treanor et al., 1996; Trupp et al.,
1996). GDNF does not bind directly to Ret, but to an a
component (GFRa), which then forms a transductionally
active complex with homodimers of Ret (Jing et al., 1996).
There are multiple GFRa proteins, GFRa-1, GFRa-2,
GFRa-3, etc. (Jing et al., 1997), and it appears that GDNF
preferentially binds to GFRa-1 (Baloh et al., 1997; Davies et
al., 1997), while neurturin (NTN) binds preferentially to
GFRa-2 (Creedon et al., 1997; Jing et al., 1997). GFRa-1 has
recently been demonstrated to be essential for the forma-
tion of the ENS; defects that are similar to those seen in the
bowel of GDNF- or Ret-deficient animals are also seen in
mice lacking GFRa-1 (Cacalano et al., 1998). Although the
effects of the knockouts of Ret, GDNF, and GFRa-1
strongly imply that the development of mammalian enteric
neurons and glia is GDNF-dependent, the effects of GDNF
on the precursors of these cells have not yet been deter-
mined. A recent study has examined the effect of GDNF on
mixed cultures of cells from the bowel (Heuckeroth et al.,
1998); however, since this investigation was not carried out
with isolated crest-derived cells, the direct effects of GDNF
on the precursors of enteric neurons could not be distin-
guished from those that might be modified by the indirect
actions of non-crest-derived cells (present in greater num-
bers) in the same cultures. The location of GFRa-1 in the
developing bowel has also not previously been demon-
strated.
The fact that there are no enteric neurons or glia below
the esophagus and adjacent stomach following the knock-
out of Ret or GDNF suggests that all of the vagal and sacral
crest-derived e´migre´s in the bowel are GDNF-dependent.
Since the initial crest-derived population that colonizes the
gut contains multipotent precursor cells, and all enteric
precursors are lost in GDNF/Ret-deficient animals, it fol-
lows that the survival and/or continued development of the
multipotent precursor is GDNF/Ret-dependent. GDNF
would thus be expected to promote the development, pro-
liferation, and/or survival of an early precursor that gives
rise both to enteric neurons and glia. GDNF might also, in
theory, exert effects on committed neural or glial progeni-
tors. Such effects might lead to indirect consequences, since
neurons and glia can affect one another’s survival. Precursor
cells would also be expected to express and/or anchor
GFRa-1. To test these hypotheses, the effects of GDNF on
the proliferation of enteric neural/glial precursors and on
the in vitro development of neurons and glia were charac-
terized as a function of fetal age and compared with those of
NT-3. The ability of GDNF to influence responses to NT-3
was also investigated. The effects of GDNF and NT-3 were
studied on preparations of crest-derived and crest-depleted
cells isolated from the fetal rat gut by immunoselection
with antibodies to p75NTR (Chalazonitis et al., 1994, 1997b,
1998; Pomeranz et al., 1993), a marker for crest-derived cells
colonizing the fetal rat bowel (Baetge et al., 1990a). The
separated crest-derived and crest-depleted populations were
also employed to identify the cells of the fetal bowel that
express and/or anchor GFRa-1 and GFRa-2. GDNF stimu-
lated the proliferation of enteric neural/glial precursors, but
NT-3 did not. GDNF also increased the proportion of
crest-derived cells that express TrkC and promoted the
development of neurons at E12, an age when NT-3 was
ineffective. Although both crest- and non-crest-derived
cells were found to express GFRa-1, only crest-derived cells
anchored GFRa-1 or GFRa-2. The observations support the
view that the ENS below the rostral foregut is derived from
a multipotent GDNF-responsive precursor cell. A prelimi-
nary report of some of these data has been presented
(Chalazonitis et al., 1997a).
MATERIALS AND METHODS
Animals. Fetal rats were obtained from timed pregnant moth-
ers (Sprague Dawley; Charles River, MA). The day at which a
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vaginal plug was found was designated as day 0 of gestation.
Maternal rats were asphyxiated with CO2 at gestational day 12, 14,
or 16. This procedure has been approved by the Animal Care and
Use Committee of Columbia University. The fetal bowel was
dissected aseptically from 25 to 30 fetuses per experiment.
Immunoselection. The fetal gut was dissociated as described
previously to give rise to a suspension of single cells (Chalazonitis
et al., 1994, 1997b, 1998). The dissociated cells were suspended in
a medium consisting of aMEM, supplemented with 20% horse
serum (HS; JRH Biosciences, Lenexa, KS) and 10% chick embryo
extract (CEE; from E11 embryos) and incubated for 1 h at 4°C with
a monoclonal antibody to p75NTR (IgG192, diluted to 20 mg/ml;
donated by Regeneron Pharmaceuticals Inc., Tarrytown, NY). The
incubated cells were centrifuged (at 140g for 5 min), washed, and
resuspended in CEE and HS-free medium at a density of 107
cells/100 ml. Antibody-coated cells were decorated with magnetic
microbeads coupled to goat anti-mouse IgG (Miltenyi Biotec Inc.
Auburn, CA) and selected by passage through a magnetic field
(; 0.6 Tesla; MS, Miltenyi Biotec Inc.). Crest-derived p75NTR-
immunoreactive cells are retained by the magnetic field, while the
remainder (“residual cells”) pass through. The residual cells are
collected first, the magnetic field is then released, and the immu-
noselected cells are finally flushed from the column with 1.5 ml of
medium. Even though more total cells were obtained from the
bowel as it enlarged with age, and more crest-derived cells were
thus immunoselected, age did not significantly affect the propor-
tion of cells that were immunoselected with antibodies to p75NTR
(Fig. 1). At E12, an average of 1.1 6 0.3 3 106 immunoselected cells
were obtained in each experiment (n 5 6), which represented
15.7 6 3.5% of the cells in the starting cell suspension. At E14, an
average of 5.0 6 1.6 3 106 immunoselected cells were obtained in
each experiment (n 5 3), which represented 17.8 6 4.7% of the cells
in the starting cell suspension at that age. At E16, an average of
13.1 3 106 immunoselected cells were obtained in each experi-
ment, which represented 20.1% of the cells in the starting cell
suspension.
Tissue culture. Immunoselected and residual cells were always
plated for culture at an equal cell density in each experiment. The
density at which these cells were plated, however, varied with the
type of vessel. Because fewer immunoselected cells could be
obtained at E12 than at later ages, cells from the E12 bowel (1.2 3
105 cells/ml) were grown as microcultures on glass coverslips
(RESY No. 1001, Germany; 12-mm-diameter). These coverslips
were placed in tissue culture wells (Nunc No. 176740). Cells from
the E14 or E16 gut (1.8 3 105 cells/ml) were cultured in 35 mm
dishes (Falcon, No. 3001) or, alternatively, cells (7.0 3 104 cells/ml)
were plated in 20-mm-chamber slides (Nunc No. 177429). In all
cases, the substrate was rat tail collagen and laminin (isolated from
the Englebreth–Holm–Swarm mouse tumor; Becton Dickinson
Labware, Bedford, MA). Cells were grown in Basic Brazeau Medium
(BBM) (Ziller et al., 1983), a defined medium used previously to
study the development of enteric neurons in vitro (Chalazonitis et
al., 1994, 1997b, 1998). At the time of plating, the medium was
supplemented with 20% horse serum (HS) to promote the adher-
ence of cells to the substrate. After 18 h, this medium was changed
to serum-free BBM. The cultures were then fed on the fourth day in
vitro. Cells were cultured for a maximal time of 7 days. When
growth factors, GDNF (rat r; 10 ng/ml; R&D Systems, Berkeley,
CA) or NT-3 (human r, 40 ng/ml; Regeneron Pharmaceuticals,
Tarrytown, NY) were studied, the factors were added to the
medium at the time of initial plating and remained present
thereafter. Control cultures contained only the vehicle in which
the growth factors were suspended (0.5% bovine serum albumin in
BBM). Each type of culture was maintained in triplicate. Following
the culture period, cells were fixed for 1 h with 4% formaldehyde
(freshly prepared from paraformaldehyde) in 0.1 M phosphate-
buffered saline (PBS) to permit the immunocytochemical demon-
stration of cell markers. In the case of demonstration of the
proliferating cell nuclear antigen (PCNA, see below), fixation lasted
30 min with 1% paraformaldehyde.
Immunocytochemistry. For detection of antigens in cultured
cells, fixed cultures were first rinsed with 0.1 M phosphate-buffered
saline (PBS; pH 7.4) containing 0.1% Triton X-100 (Sigma) to
permeabilize the cells. The preparations were incubated with
PBS–Triton containing 10% HS or 5% goat serum (GS) to reduce
nonspecific background staining. Cultures were exposed as whole
mounts to primary antibodies suspended in PBS–Triton, containing
4% HS or 2% GS (Table 1). Antibodies to GFRa-1, GFRa-2, and
PCNA were incubated from 48 to 72 h at 4°C. All other primary
antibodies were incubated overnight at room temperature. PCNA
was detected with primary antibodies directly coupled to fluores-
cein isothiocyanate. All other antigens were visualized indirectly.
After treatment of cultures with primary antibodies, the cultures
were rinsed and exposed for 3 h at room temperature to an
appropriate affinity-purified species-specific secondary antibody.
Secondary antibodies included goat anti-rabbit IgG and goat anti-
mouse IgG coupled to either alkaline phosphatase (diluted 1:50,
Kirkegaard & Perry Labs, Gaithersburg, MD) or biotin (ABC elite
kit, Vector Labs, Burlingame, CA). The biotinylated probes were
detected with streptavidin–HRP. Sites of bound alkaline phospha-
tase were visualized with a commercial kit (blue product, Vec-
FIG. 1. The efficiency of immunoselection is independent of fetal
age. The numbers of total cells (n) and crest-derived cells (F)
obtained by immunoselection from dissociated preparations of
fetal bowel increase as a function of age between E12 and E16;
nevertheless the proportion of the dissociated cell population that
is immunoselected (}) remains constant during the same period.
The immunoselection procedure effectively removes crest-derived
cells from the dissociated mixture of cells obtained from the fetal
bowel. Even after 1 week in culture, ,0.02% of residual cells are
p75NTR-immunoreactive and the ratio of p75NTR-immunoreactive
cells in the crest-derived cultures to those in the residual cultures
is extremely high, 1214:1.
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tastain SK No. 5300), while HRP was visualized with 3,39-
diaminobenzidine and H2O2 (Vectastain SK No. 4100). Controls, in
which the primary antibody was omitted or substituted with
preimmune serum, were always included with each procedure.
Immunocytochemistry was used to locate GFRa-1 in frozen
sections of E13 fetal rats and adult rat intestine. Freshly dissected
fetuses or segments of bowel were frozen in liquid N2, embedded in
OCT medium (Lipshaw), and stored at 280°C until used. Sections
(10 mm) were cut at 4°C with a cryostat–microtome and collected
on gelatin-coated glass slides. Sections were exposed to primary
antibodies to GFRa-1 (diluted 1:3000–1:500) for 24 h at 4°C. Sites
of immunostaining were visualized with biotinylated secondary
antibodies and streptavidin-HRP as described above.
Cell counts and statistical data. Cells were counted using
Hoffman modulation contrast, bright field, or fluorescence optics,
as previously described (Chalazonitis et al., 1994, 1997b). Means
were compared by ANOVA (STATVIEW 4.1 program for the
Macintosh computer).
Detection of mRNA-encoding GFRa-1. Reverse transcription
and the polymerase chain reaction (RT–PCR) were used to identify
mRNA encoding GFRa-1 in the p75NTR-immunoselected and re-
sidual cell populations. Total RNA was extracted with 6 M
guanidinium thiocyanate (Chomczynski and Sacchi, 1987), incu-
bated with Moloney murine leukemia virus (MMLV) reverse tran-
scriptase (Gibco–Bethesda Research Labs, Bethesda, MD) in the
presence of random primers using the protocol provided by the
supplier. The resulting cDNA was amplified using primers de-
signed from the sequence of rat GFRa-1 (Jing et al., 1996). The
forward sequence was 59-AGTGCCTGAAGGAACAGAG-39 (cor-
responding to nucleotides 405–423) and the reverse sequence was
59 -TTGTCGAAGAACTGCCTG-39 (corresponding to nucleotides
889–906). Thirty-five PCR cycles were carried out as follows: 94°C
for 0.5 min, 57°C for 45 s, 72°C for 0.5 min. The primers were used
at a concentration of 0.34 mM. cDNA encoding the 150 kDa
neurofilament protein (NF-M) was amplified (28 cycles carried out
as follows: 94°C for 0.5 min, 56°C for 1 min, 72°C for 45 sec) using
the following primers: 59-GAATACCAGGATCTCCTTAAC-39
(corresponding to nucleotides 178–198) and the reverse sequence
was 59-GGCCTCTTCCTTCTCCTC-39 (corresponding to nucleo-
tides 490–507) (Julien et al., 1986). cDNA encoding b-actin was
amplified (25 cycles, with an annealing temperature of 56°C) using
the following primers: 59-GTGGGCCGCTCTAGGCACCAA-39
(forward) and 59-CTCTTTGATGTCACGCACGATTTC-39 (re-
verse). PCR products were separated by electrophoresis through a
1.5% agarose gel.
RESULTS
GDNF, but Not NT-3, Increases both the Number
of Neurons and Their Precursors
Cultures of E12 immunoselected and residual cells were
exposed for 1 week to GDNF, NT-3, or vehicle. Expression
of nestin immunoreactivity was used as a marker for
precursor cells, and peripherin immunoreactivity was used
to mark cells committed to develop as neurons. The num-
bers both of nestin- and peripherin-immunoreactive cells in
cultures of immunoselected cells exposed to GDNF (10
ng/ml) were each about 15-fold greater than those found in
TABLE 1
Immunocytochemical Markers Used to Identify Cells Differentiating in Vitro
Marker Cell type Dilution Antibody Source Reference
p75NTR Cells of
neural
crest
origin
20 mg/ml Mouse
monoclonal
Regeneron,
Tarrytown, NY
(Baetge et al., 1990a; Bannerman
and Pleasure, 1993)
Nestin Neural/glial
precursor
1:500 Mouse
monoclonal
PharMingen, San
Diego, CA
(Friedman et al., 1990;
Hockfield and McKay, 1985;
Lendahl et al., 1990)
Peripherin Neurons 1:750 Rabbit
polyclonal
R. Liem and L.
Greene,
Columbia Univ.,
New York, NY
(Baetge et al., 1990a; Portier et
al., 1984)
S-100 Glia 1:400 Rabbit
polyclonal
Sigma, St. Louis,
MO
(Bishop et al., 1985; Ferri et al.,
1982; Kawana et al., 1988;
Scheuermann et al., 1989)
TrkC Cells
responsive
to NT-3
1:100 Rabbit
polyclonal
Barbara
Hempstead,
Cornell Med.
Coll.
(Donovan et al., 1996; Tsoulfas
et al., 1993)
GFRa1, a2 Responsive
to GDNF
family
1:100 Rabbit
polyclonal
C.F., Iban˜ez,
Karolinska Inst.,
Stockholm,
Sweden
(Davies et al., 1997)
PCNA Proliferating
cells
1:200 Mouse
monoclonal
PharMingen, San
Diego, CA
(Garcia et al., 1989; Hyde-Dunn
and Jones, 1997)
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cultures exposed either to vehicle or NT-3 (40 ng/ml) (Fig. 2;
compare Figs. 3D [vehicle] and 3F [GDNF-treated]). In
contrast to GDNF, NT-3 did not significantly change the
number of precursors or neurons. These observations sug-
gest that GDNF sensitivity of enteric cells able to develop
as neurons arise before these cells become responsive to
NT-3 (which had previously been demonstrated in older
fetuses; see below).
The immunoreactivity of the precursor marker, nestin,
appeared only in scattered islands of cells in control cultures
of immunoselected cells (Fig. 3A). In contrast, following
exposure to GDNF, nestin-immunoreactive cells seemed to
be more evenly dispersed over the culture dish forming a
dense cellular mat (Fig. 3B). The nestin immunoreactivity was
intracytoplasmic and filamentous (cytoskeletal) in nature,
outlining the nonimmunoreactive nuclei, around which it
was most dense. Processes were also nestin-immunoreactive;
however, the cytoskeletal nature of the nestin immunoreac-
tivity made it difficult to assess cell size or shape in cells
stained only to demonstrate this immunogen (Fig. 3C).
In preparations in which double-label immunocytochem-
istry was used to visualize nestin and peripherin immuno-
reactivities simultaneously (Figs. 3D–3F), there was very
little coincident localization of the two antigens (0.6 6
0.1% of total cells in control cultures). Again, GDNF
increased the number of cells stained individually by the
two antibodies; however, even after stimulation with
GDNF there was very little coexpression of nestin and
peripherin immunoreactivities in the same cells (Fig. 3E;
0.9 6 0.2% of total cells; P is ns vs control). The total
number of cells expressing nestin and peripherin immuno-
reactivities did not account for all of the cells in either
control or GDNF-treated immunoselected cell cultures.
The cells that were not immunostained by either antibody
constituted 89.0 6 3% of the total number of cells in
control cultures and 58.4 6 1% of cells in cultures exposed
to GDNF. Since the number of cells that were neither
nestin- nor peripherin-immunoreactive was increased 2.2 6
0.1-fold by GDNF, at least some of the nonimmunostained
cells must be GDNF-responsive. The nonimmunostained
cells may be uncommitted crest-derived precursors that
have not acquired nestin. Such cells might do so at a later
stage (see also experiments on proliferation below).
A close examination of the cultures of immunoselected
cells revealed that the clustering of peripherin-immuno-
reactive neurons that was evident in control cultures was
preserved even after treatment with GDNF (Fig. 3F). What
appeared to be a more uniform distribution of cells when
cultures were examined at low magnification was caused by
the GDNF-induced expansion of the cellularity of the neural
islands (Fig. 4 and compare Fig. 3D with 3F). The number of
neurons per cluster was greatly increased by treatment with
GDNF from 16 6 2 to 43 6 3 (n 5 50; P , 0.001). The
GDNF-promoted clustering of neurons is compatible with the
idea that GDNF stimulates the development of colonies of
neurons from a common progenitor.
Peripherin-immunoreactive cells were extremely rare
(,0.1%) in control cultures of the residual cells, which were
not immunoselected at E12 with antibodies to p75NTR (not
illustrated). Following exposure of the residual cells to GDNF,
however, small clusters of peripherin-immunoreactive cells
appeared. Even after treatment with GDNF, however, the
proportion of peripherin-immunoreactive cells remained
quite low (;2%) in the cultures of residual cells. These
observations suggest that small numbers of neuronal precur-
sors are present in the residual cell population, although these
cells are not readily detected in the absence of GDNF.
The Developmental Response of Enteric Neural
Precursors to GDNF Decreases at the Age When
Cells Become Responsive to NT-3
The magnitude of the response of immunoselected crest-
derived cells to GDNF decreased significantly (P , 0.001)
between E12 and E14 (Fig. 5A). GDNF was still effective at
E14 in promoting the development of peripherin-expressing
neurons, and it continued to be effective at E16. When cells
were isolated by immunoselection at E12 and cultured for a
week in the absence of GDNF, the proportion of surviving
nestin-immunoreactive cells was quite low (2.3 6 1.3%; n 5
3). In contrast, when cells were isolated by immuno-
selection at E14 and similarly maintained for 1 week in the
absence of GDNF, the proportion of nestin-immunoreactive
cells was substantial (26.5 6 0.5%; n 5 3) and significantly
greater than at E12 (P , 0.001). The precursor cells that are
isolated at E14 are evidently better able to survive in vitro in
the absence of GDNF than those isolated at E12, perhaps
because the later precursors have been exposed for a longer
time to GDNF in situ. Both the effectiveness of GDNF and the
dependence of neuronal precursors (nestin-immunoreactive
cells) on GDNF, therefore, are maximal at E12.
Responses to NT-3 differed from those to GDNF, in the
FIG. 2. GDNF, but not NT-3, increases the numbers of crest-
derived precursors and neurons developing in cultures of cells
immunoselected with antibodies to p75NTR at E12. Cell-type-
specific intermediate filament markers, demonstrated immunocy-
tochemically, were nestin for precursor cells and peripherin for
neurons. Vehicle-treated cultures each contained 5.3 6 1.1 3 103
precursors and 4.4 6 0.9 3 103 neurons (n 5 7).
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sense that NT-3 did not significantly affect the develop-
ment of neurons at E12 but acquired the ability to do so at
E14 (Fig. 5B; P , 0.001 vs control). NT-3 was thus ineffec-
tive at a time when cells were maximally responsive to
GDNF and became effective at a time when the effective-
ness of GDNF was declining. The ability of NT-3 to
promote neuronal development was maintained at E16. It
should be noted that even when NT-3 was maximally
active at E14 (approximately twofold enhancement), the
promotion of neuronal development by NT-3 was less than
that of GDNF (approximately fourfold enhancement) at the
same age (compare Fig. 5A with 5B).
GDNF Increases the Proportion of Crest-Derived
Cells That Express TrkC Immunoreactivity
Since crest-derived cells respond to GDNF before NT-3, it
is possible that neuronal precursors require GDNF stimu-
FIG. 3. Immunocytochemical visualization of the effects of GDNF on the expression of nestin and peripherin in cultures of cells
immunoselected with antibodies to p75NTR at E12. Cells were cultured for 1 week in defined media. Nestin immunoreactivity is illustrated
in all panels. Simultaneously demonstrated peripherin immunoreactivity is illustrated in D–F. Darkfield photomicrographs are shown in
A and B, while all remaining panels were photographed in brightfield. (A) Control. Media were supplemented only with vehicle. Nestin
immunoreactivity (bright) appears only in a small cluster of cells (arrow). (B) GDNF. A massive increase has been induced in the numbers
of nestin-immunoreactive cells, which now form a carpet of cells that fills the culture dish (compare to A). (C) GDNF. At Higher
magnification the filamentous nature of intracellular nestin immunoreactivity (arrow) is apparent. (D–F) Peripherin-immunoreactive cells
are visualized with DAB (dark brown) and nestin-immunoreactive cells are visualized with alkaline phosphatase (red). (D) Very few nestin-
or peripherin-immunoreactive cells (arrow) are evident in control cultures which were exposed only to vehicle. (E) GDNF induces a large
network of peripherin-immunoreactive neurons (arrowhead) to develop and also increases the numbers of nestin-immunoreactive cells
(arrow). Note that the distributions of nestin and peripherin immunoreactivities are not coincident. (F) In the presence of GDNF, nestin-
and peripherin-immunoreactive cells develop in clusters. The calibration bars, 100 mm.
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lation to become NT-3-responsive. If cells are able to
respond to NT-3, then they would be expected to express
TrkC (Lamballe et al., 1991; Tessarollo et al., 1993). The
effect of GDNF on the expression of TrkC by crest-derived
cells was therefore investigated. TrkC-immunoreactive
cells were identified immunocytochemically with antibod-
ies that react with the catalytic region of the TrkC tyrosine
kinase domain (Buj-Bello et al., 1995; Donovan et al., 1996;
Maxwell et al., 1996). These antibodies do not cross-react
significantly with TrkA or TrkB. Crest-derived cells were
immunoselected from the E12 fetal bowel and cultured for
7 days in the presence or absence of GDNF (10 ng/ml). Very
few TrkC-immunoreactive cells were observed in the con-
trol cultures (Fig. 6A); however, many cells expressed TrkC
immunoreactivity in cultures exposed to GDNF (Figs. 6B
and 6C). The GDNF-induced increase in TrkC-
immunoreactive cells was about 12-fold.
Promotion of Neuronal Development by GDNF and
NT-3 Are Not Additive
To determine whether the effects of GDNF and NT-3
on the in vitro development of enteric neurons are
additive, the factors were applied alone and in combina-
tion to crest-derived cells immunoselected from the fetal
gut at E12, E14, and E16. Supramaximal concentrations
of NT-3 (40 ng/ml) (Chalazonitis et al., 1994) and GDNF
(10 ng/ml) (Jing et al., 1996) were used. As previously
noted, the effect of GDNF in promoting the in vitro
development of neurons was maximal at E12, while NT-3
at this age was ineffective (Table 2). The effects of
exposing E12 cultures to GDNF plus NT-3 on the devel-
opment of neurons were not significantly different from
those of exposing sister cultures to GDNF alone (Table 2).
At E14 and E16, when the relative effectiveness of GDNF
decreased, and NT-3 was able, by itself, to promote the
development of neurons, the effects of the combination
of GDNF and NT-3 were still not significantly different
from the effects of GDNF alone (Table 2). GDNF and
NT-3, therefore, are not additive in promoting the devel-
opment of enteric neurons in vitro.
GDNF, but Not NT-3, Increases the Absolute
Number of Cells in Cultures of p75 NTR-
Immunoselected Cells at E12
When cells that were immunoselected at E12 with anti-
bodies to p75NTR were grown in the presence of GDNF for
7 days the absolute number of cells/culture was over
threefold greater than that found in vehicle-treated sister
cultures (Fig. 7). In contrast, the addition of GDNF did not
affect the total number of cells/culture when it was added
to cultures of the residual cells, which remained after the
crest-derived cells were removed by the same immuno-
selection procedure (Fig. 7). In contrast to E12, the total
number of cells was not altered by the addition of GDNF to
cultures of immunoselected or residual cells at E14 or E16
(Fig. 7). Unlike GDNF, NT-3 was unable to increase abso-
lute cell numbers at any age, no matter whether it was
added to cultures of immunoselected or residual cells (Fig.
7). The selective increase in the total number of crest-
derived cells induced by GDNF at E12 is consistent with
FIG. 4. GDNF stimulates the formation of neurons in clusters. The number of neurons/cluster is shown as a frequency histogram. Note
that GDNF increases the proportion of clusters with large numbers of neurons.
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the possibility that it stimulates the proliferation of at least
some of the cells in this population. The proliferative effect
of GDNF is not shared by NT-3.
GDNF Increases the Expression of PCNA in
Cultures of p75 NTR-Immunoselected Cells at E12
The immunoreactivity of PCNA was examined in cul-
tures of cells immunoselected with antibodies to p75NTR at
E12 to test the hypothesis that GDNF stimulates prolifera-
tion of cells in this population. PCNA is an accessory
protein for DNA polymerases d and e and is a good immu-
nocytochemical marker for replicating cells in the S-phase
of the cell cycle (Assy et al., 1998; Ellison and Stillman,
1998; Hyde-Dunn and Jones, 1997; Tomlinson and Mackey,
1998). Cultures were maintained for 3.5 or 7 days in the
presence or absence of GDNF. GDNF increased the propor-
tion of cells with PCNA-immunoreactive nuclei by more
than threefold (Figs. 8 and 9); the effect of GDNF on cells
cultured for 3.5 days was virtually identical to that on cells
cultured for 7 days. Many, but not all, of the cells with
PCNA-immunoreactive nuclei were nestin-immuno-
reactive (Fig. 9). These data support the view that GDNF
stimulates the proliferation of cells in a neuronal or glial
lineage. The proliferating cells that do not express nestin
could be immature and not yet specified to the point where
they display nestin. Alternatively, it is possible that a
subset of enteric neurons and/or glia is derived from pro-
genitor cells that do not express nestin.
GDNF Does Not Promote the Development of
Enteric Glia
Glia were identified by using the immunoreactivity of
S-100 as a marker. Crest-derived cells were again immuno-
selected from the fetal gut at E12, E14, and E16. The cells
were cultured for 1 week in the presence of GDNF (10
ng/ml). GDNF did not affect the proportion of S-100-
immunoreactive cells in cultures of cells immunoselected
at E12 (Table 3); however, there were significantly fewer
S-100-immunoreactive cells in the GDNF-exposed E14 and
E16 cultures than in the age matched vehicle-treated con-
trols (Table 3). In contrast to GDNF, NT-3 increased the
proportion of S-100-immunoreactive cells when added to
cultures of cells that were immunoselected at E14 (Table 3).
The ability of NT-3 to promote glial development has been
reported previously (Chalazonitis et al., 1994). The S-100-
immunoreactive cells that developed in culture did not
necessarily do so in association with neurons (Fig. 10). The
cells tended to form aggregates of small slender stellate
FIG. 5. Promotion of neuronal development by GDNF is maximal at E12, while that by NT-3 is not seen prior to E14. The number of
neurons (expressed as a percentage of the vehicle-treated control) is shown at E12, E14, and E16. The mean numbers of neurons in control
cultures were 4.4 6 0.9 3 103 (11-mm-diameter coverslip) at E12, 13.2 6 1.4 3 103 (35-mm-diameter Falcon dish) at E14, and 34.7 3 103
(20-mm Nunc square dish) at E16. Differences between means were considered significant if P was ,0.05. (A) GDNF. The difference
between GDNF-treated and control cultures is significant at each age. Comparisons were made between 11 cultures at E12, 19 cultures at
E14, and 4 cultures at E16. (B) NT-3. The difference between NT-3-treated and control cultures is not significant at E12, but is significant
at E14 and E16. Comparisons were made between 14 cultures at E12, 35 cultures at E14, and 6 cultures at E16.
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cells. The morphology of the S-100-immunoreactive cells
developing in the presence of GDNF (Fig. 10A) was similar
to that developing in control cultures (Figs. 10B and 10C).
These observations indicate that GDNF does not enhance
the development of glia as it does of neurons and, when
applied relatively late in enteric development, may even
skew the developing population toward the neuronal lin-
eage.
Although Only Neurons Are GFRa-1-
Immunoreactive, mRNA Encoding GFRa-1 Is
Expressed by both Crest-Derived and Non-Crest-
Derived Cells
Since an “a component” is required for the efficient
stimulation of Ret by GDNF or neurturin (Creedon et al.,
1997; Davies et al., 1997; Jing et al., 1996; Klein et al., 1997;
Treanor et al., 1996; Trupp et al., 1996, 1997), the biosyn-
thesis and localization of GFRa-1 and GFRa-2 were inves-
tigated in cells isolated from the fetal bowel. Crest- and
non-crest-derived cells were isolated and separated from
fetal gut by immunoselection at E14. To determine the
effectiveness of immunoselection, RT–PCR was used to
analyze mRNA-encoding NF-M, which was employed as a
neuron-specific marker protein. mRNA-encoding NF-M
was found only in the p75NTR-immunoselected cell popu-
lation, and not in the residual cells (Fig. 11); therefore, there
must be little or no neuronal contamination of the residual
cell fraction. In contrast to NF-M, mRNA-encoding GFRa-1
was found to be expressed both by the immunoselected and
the residual cell populations (Fig. 11). These observations
suggest that both crest-derived and non-crest-derived cells
of the E14 fetal gut synthesize GFRa-1.
Immunocytochemistry was employed to locate GFRa-1
protein. Since GFRa-1 is a peripheral protein that becomes
linked to the plasma membrane by a glycosylphosphoinosi-
tol anchor, it follows that the cells that bind the protein
may not be the cells that synthesize it (Buj-Bello et al.,
1997; Creedon et al., 1997; Jing et al., 1996; Klein et al.,
1997; Yu et al., 1998). In marked contrast to the mRNA,
GFRa-1 immunoreactivity was found to be almost com-
pletely confined to the immunoselected cultures (Figs. 12
and 13). All of the GFRa-1-immunoreactive cells in these
cultures were process-bearing and exhibited the morphol-
ogy of neurons (Fig. 13A). Both perikarya and neurites were
GFRa-1-immunoreactive. Two populations of cells could
be defined by the intensity of immunoreactivity. Many
more cells were found to be GFRa-1-immunoreactive in
cultures treated with GDNF than in controls. After treat-
ment with GDNF, rare GFRa-1-immunoreactive cells were
even noted in the cultures of residual cells. Again, however,
the GFRa-1-immunoreactive cells were process-bearing and
appeared to be neurons. These observations suggest that
GFRa-1 selectively binds to the plasma membranes of cells
in a neuronal lineage, although both crest- and non-crest-
derived cells probably synthesize the protein. The increased
FIG. 6. GDNF increases the number of cells expressing TrkC
immunoreactivity in cultures of cells immunoselected with
antibodies to p75NTR at E12. (A) Control. Media were supple-
mented only with vehicle. Very few cells express TrkC (arrow)
(0.8 3 103 cells/12-mm-diameter coverslip). These cells are
process-bearing and have a neuronal morphology. (B) GDNF. A
massive increase has been induced in the numbers of TrkC-
immunoreactive cells (arrow) (9.7 3 103 cells/coverslip), which
are a subset of the neurons that have developed in a large cluster
(compare to A). (C) GDNF. At higher magnification, the TrkC-
immunoreactive cells (arrow) can be recognized as neurons. Both
cell bodies and neurites are TrkC immunoreactive. Calibration
bars: A and B, 100 mm; C, 50 mm.
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number of cells found to contain GFRa-1-immuno-
reactivity in cultures treated with GDNF could reflect
either an ability of GDNF to induce GFRa-1 expression
or, alternatively, the GDNF-induced increase in neuronal
development.
In contrast to GFRa-1-immunoreactive cells, which were
abundant in the immunoselected population even in the
absence of treatment with GDNF, very few cells in either
the immunoselected or the residual populations exhibited
GFRa-2 immunoreactivity (;0.4% of total cells). The addi-
tion of GDNF to cultures of immunoselected cells did
increase the number of cells that were GFRa-2-
immunoreactive (;1.6% of total cells); however, even in
the presence of GDNF, the proportion of cells that were
GFRa-2-immunoreactive was very small (Fig. 14). The
GFRa-2-immunoreactive cells were always found in iso-
FIG. 7. GDNF increases the absolute number of cells in cultures of cells immunoselected with antibodies to p75NTR at E12. The total
number of cells was determined in each culture and expressed as a percentage of the mean number present in cultures exposed only to
vehicle (dotted line 6 SEM). In contrast to the p75NTR-immunoselected cells, GDNF does not affect cultures of the E12 residual cells.
GDNF fails to increase the total number of cells in cultures of immunoselected or residual cells prepared at E14 or E16. NT-3 does not cause
an increase in the total number of cells in cultures either of immunoselected or residual cells isolated at any age. Vehicle-treated
immunoselected cultures contained 65.8 6 6.5 3 103 cells at E12 (n 5 16), 438.8 6 20 3 103 cells at E14 (n 5 16), and 615.76 17.5 3 103
at E16 (n 5 4). Vehicle-treated residual cultures contained 49.2 6 5.2 3 103 (n 5 6) cells at E12 (n 5 16) and 351.9 6 26.1 3 103 cells at E14
(n 5 7).
TABLE 2
GDNF and NT-3 Are Not Additive in Promoting Neuronal Development
Factors
Relative number of neurons (%)a
E12 P E14 P E16 P
GDNF 1342 6 126 , 0.001 vs NT-3 369 6 79 , 0.001 vs vehicle; 327 6 9 —
n 5 4 ns vs GDNF 1 NT-3 n 5 4 ns vs NT-3 or n 5 2,
GDNF 1 NT-3 at E14 range
NT-3 120 6 20 ns vs vehicle 210 6 15 , 0.001 vs vehicle 172 6 10 , 0.001 vs vehicle
n 5 7 n 5 6 , 0.02 vs NT-3 at E12 n 5 4 , 0.001 vs NT-3 at
E12
GDNF 1 NT-3 1075 6 45 , 0.001 vs NT-3 322 6 54 ns vs NT-3 at E14 373 6 46 , 0.01 vs NT-3 at
E16
n 5 4 n 5 3 n 5 3
a The number of peripherin-immunoreactive neurons as a percentage of the number found in paired vehicle-treated control cultures.
The mean neuronal density in vehicle-treated cultures was 39 6 8 neurons/mm2. This represented a mean of 4439 6 976 neurons per
dish in microcultures and 38,713 6 15,550 neurons/dish in 35-mm Falcon dishes. The number of neurons/mm2 found in
vehicle-treated microcultures did not differ significantly from the neurons/mm2 found in similarly treated cultures grown in Falcon
dishes.
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lated aggregates. The individual cells were process-bearing
and appeared to be neurons.
GFRa-1 immunoreactivity was detected in situ in E13
rats. At this time, small clusters of primitive neurons
exhibited GFRa-1 immunoreactivity in the fetal stomach
and small, and large intestines (Fig. 15A). Also at this time,
they were immunostained by antibodies to GFRa-1, neu-
rons in dorsal root ganglia (Fig. 15C), nerve processes in
muscles of the developing body wall (Fig. 15D), spinal
motor neurons, periaortic sympathetic neurons, and renal
tubules (not illustrated). GFRa-1 immunoreactivity contin-
ued to be detectable in neurons of both submucosal (Fig.
15E) and myenteric ganglia (Figs. 15E and 15F) in the adult
bowel.
DISCUSSION
GDNF Selectively Affects an Early Precursor
Common to the Vagal and Sacral Populations of
Crest-Derived E´migre´s in the Bowel
Data obtained in the current study support the hypoth-
esis that GDNF promotes the survival and/or development
of an early precursor of enteric neurons. When applied in
vitro to crest-derived cells isolated from the fetal rat bowel
early in development, GDNF enhanced both the prolifera-
tion of neuronal precursors and the in vitro development of
neurons. At E12, but not later, GDNF increased the propor-
tion of crest-derived cells that exhibit PCNA, a marker for
proliferation (Assy et al., 1998; Ellison and Stillman, 1998;
Hyde-Dunn and Jones, 1997; Tomlinson and Mackey,
FIG. 8. GDNF increases the proportion of proliferating cells that
express PCNA in cultures of cells immunoselected with antibodies
to p75NTR at E12. Vehicle-treated cultures contained 1.5 6 0.4 3
103 (n 5 3) cells with PCNA-immunoreactive nuclei after 3.5 days
and 4.3 6 2.3 3 103 (n 5 4) after 7 days of culture.
FIG. 9. Simultaneous immunocytochemical demonstration of
PCNA and nestin in cultures of cells immunoselected with anti-
bodies to p75NTR at E12. (A) Control. Media were supplemented
only with vehicle. PCNA-immunoreactive nuclei were visualized
with FITC (bright fluorescence), while nestin-immunoreactive
intermediate filaments were visualized with DAB and appear
black. Some of the cells with PCNA-immunoreactive nuclei con-
tain nestin immunoreactivity (arrow). (B) GDNF. Many more cells
have PCNA-immunoreactive nuclei. The coincident distribution
of PCNA and nestin immunoreactivities is partially obscured by
the very large number of PCNA-immunoreactive nuclei; however,
some doubly labeled cells can still be discerned (arrow). The
calibration bars, 100 mm.
TABLE 3
Effects of GDNF and NT-3 on Glial Development
Treatment
Relative number of glia (% control)a
E12 E14–16 (n)b
P vs vehicle
at E14–16
Vehicle 100 6 17 100 6 6 (4)
GDNF (10 ng/ml) 91 6 9 48 6 6 (4) , 0.001
NT-3 (40 ng/ml) — 235 6 24 (8) , 0.001
a The number of S-100-immunoreactive cells in GDNF- or NT-
3-treated cultures were counted and compared to the number of
cells in sister cultures exposed only to the vehicle and grown under
identical conditions. Data are expressed as the percentage of the
number counted in the vehicle-treated controls. The number (per
mm2 of culture area) of S-100-immunoreactive cells in vehicle-
treated cultures was 80 6 14 at E12, and 58 6 24 at E14–16.
b n, number of cultures.
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1998), and nestin, a marker for neuronal (and possibly glial)
progenitors (Friedman et al., 1990; Hockfield and McKay,
1985; Lendahl et al., 1990) as well as peripherin, a marker
for cells specified to be neurons. GDNF has also been found
to stimulate the incorporation of tritiated thymidine by
crest-derived cells immunoselected from the murine bowel
(Wu et al., 1997) and the uptake of bromodeoxyuridine by
cells immunoselected from the quail gut with antibodies to
HNK-1 (Hearn et al., 1998). At later ages, E14 and E16,
GDNF no longer stimulated the proliferation of precursor
cells and was less effective in promoting neuronal develop-
ment. These data are consistent with the idea that GDNF-
responsive cells are present in the early fetal bowel but
decline in number as a function of age.
In contrast to GDNF, NT-3, which has previously been
found to promote the in vitro development of enteric
neurons (Chalazonitis et al., 1994), did not stimulate the
proliferation of crest-derived cells at any age and was unable
to promote neuronal development prior to age E14. Like
NT-3, endothelin-3, another factor that has been demon-
strated to exert a mitogenic effect on primary cultures of
neural crest cells (Lahav et al., 1996), also fails to stimulate
the proliferation of enteric crest-derived cells (Wu et al.,
1997). The early mitogenic action of GDNF on enteric
crest-derived cells, therefore, is relatively specific. The
proliferative response of enteric neural precursors to GDNF
is consistent with the idea that stimulation of Ret is
required to enable the population of crest-derived e´migre´s
to expand sufficiently to colonize the gut.
A major subset of patients with Hirschsprung’s disease,
in which the terminal colon is aganglionic, have heterozy-
gous loss-of-function mutations in genes encoding RET
(Edery et al., 1994; Pasini et al., 1995; Romeo et al., 1994),
and a small subset has mutations in genes encoding GDNF
(Angrist et al., 1998; Ivanchuk et al., 1996). In contrast, the
homozygous knockout of genes encoding Ret (Schuchardt
et al., 1994) or GDNF (Moore et al., 1996; Pichel et al.,
1996; Se´nchez et al., 1996) causes the entire bowel to
become aganglionic below the rostral foregut. We propose
that in the setting of decreased Ret activation in patients
with Hirschsprung’s disease the population of enteric crest-
FIG. 10. Relatively small numbers of S-100-immunoreactive glia
develop in cultures of cells immunoselected with antibodies to
p75NTR at E16. (A) GDNF. A small cluster of relatively isolated
S-100-immunoreactive cells can be seen (arrow). (B) Control. Media
were supplemented only with vehicle. More cells are S-100-
immunoreactive (arrow) than in A. (C) Control. At higher magni-
fication, the S-100 immunoreactivity fills the cytoplasm of thin
cells that extend short processes. The calibration bar, 50 mm.
FIG. 11. mRNA-encoding GFRa-1 is present both in the crest-
derived population of cells immunoselected from the fetal rat gut at
E14 with antibodies to p75NTR and in the non-crest-derived re-
sidual cells. RNA was extracted from the positively and negatively
immunoselected cells and used to assay mRNA encoding GFRa-1,
NF-M, and b-actin by RT–PCR. Sel, immunoselected cells; Res,
residual cells; M, size ladder. The size of the PCR products
(GFRa-1, 502 bp; NF-M, 330 bp; b-actin, 540 bp) corresponded to
those predicted from the selected primers.
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derived cells does not expand to a size sufficient to colonize
the entire gut. The terminal colon, which lies at the ends of
both vagal and sacral migratory pathways, thus remains
uncolonized and becomes aganglionic. This proposal views
the pathogenesis of the aganglionosis that occurs in RET- or
GDNF-deficient patients as qualitatively different from
that which occurs in individuals with mutations in genes
encoding endothelin-3 (Edery et al., 1996; Hofstra et al.,
1996) or its preferred receptor, endothelin B (Puffenberger et
al., 1994). The pathogenesis we postulate for the agangli-
onosis associated with GDNF/RET mutations would be
neural crest autonomous, while that which occurs in mice
with natural or targeted mutations in endothelin-3 or the
endothelin B receptor is known not to be so (Jacobs-Cohen
et al., 1987; Kapur et al., 1993, 1995; Rothman et al., 1993a).
Exposure of enteric crest-derived precursors to GDNF in
vitro stimulates their proliferation and promotes the devel-
opment of neurons. In contrast, when added to cultures of
crest-derived cells from the fetal bowel, ET-3 fails to stimu-
late proliferation and inhibits neuronal development (Hearn
et al., 1998; Wu et al., 1997). Furthermore, an abnormality
of the extracellular matrix of the colon (increased expres-
sion of laminin-1) has been demonstrated to occur when
ET-3 is deficient that does not occur when Ret is defective
(Rothman et al., 1996). These observations suggest that the
terminal colon can become aganglionic either because of an
FIG. 12. GFRa-1 immunoreactivity is selectively exhibited by neurons in cultures of crest-derived cells immunoselected from the fetal
rat gut at E12 with antibodies to p75NTR. (A) Vehicle-treated immunoselected culture. GFRa-1-immunoreactive cells (arrow) are process-
bearing and form an interconnecting neuritic network. Neurites (arrowhead) and cell bodies are GFRa-1-immunoreactive. (B) GDNF-treated
immunoselected culture. Many more GFRa-1-immunoreactive cell bodies (arrow) and neurites (arrowhead) are seen. (C) Vehicle-treated
residual culture. No cells are GFRa-1-immunoreactive. (D) GDNF-treated residual culture. Rare GFRa-1-immunoreactive neurons appear.
Both cells (arrow) and neurites (arrowhead) display GFRa-1 immunoreactivity. (E) In the absence of primary antibodies, neurons (arrow) are
not stained. Differential interference contrast microscopy is used to visualize cells. Calibration bars, 50 mm.
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abnormality of the crest-derived cells that colonize the
bowel or because of abnormalities of the non-crest-derived
elements of the tissues through which these cells migrate.
Enteric Crest-Derived Cells May Have to Be
Stimulated by GDNF to Become Responsive
to NT-3
Despite the age-related decline in the efficacy of GDNF,
its ability to promote neuronal development was always
substantially greater than that of NT-3. GDNF, moreover,
increased the number of TrkC-immunoreactive cells in the
cultures of crest-derived cells; therefore, it is possible that
prior exposure of crest-derived cells to GDNF may be a
prerequisite for NT-3-responsiveness. Since the maximal
responses of crest-derived cells to GDNF and NT-3 were
not additive, and were never greater than the effects of
GDNF alone, it is likely that the NT-3-responsive cells are
a subset of a larger pool of cells stimulated by GDNF. The
noncooperative nature of the two factors under the experi-
mental conditions used is likely to reflect the supramaxi-
mal nature of the GDNF concentration employed. Essen-
tially, if GDNF by itself induces as many neurons to
develop as can possibly do so, then it will be impossible to
obtain more neurons, even by stimulating TrkC. Another
difference between GDNF and NT-3 was that NT-3 pro-
moted the development of glia as well as neurons. In fact, at
E14–16 (but not E12), GDNF actually inhibited glial devel-
opment; therefore, at later stages GDNF appeared to en-
hance neuronal development at the expense of that of glia.
The early sensitivity of enteric crest-derived cells to GDNF
(preceding that to NT-3), the developmental regulation of
the response, and the early proliferative effect of GDNF on
neuronal precursors all support the idea that a common
crest-derived precursor of the ENS is selectively dependent
on GDNF at the time when it colonizes the bowel. Since
the knockout of Ret affects all of the enteric crest-derived
e´migre´s of the vagal and sacral, but not the truncal lineage
of enteric precursors (Durbec et al., 1996), it is apparent that
GDNF/Ret stimulation is only required for the develop-
ment of those parts of the ENS that are formed by vagal
and/or sacral crest-derived cells.
The Effects of GDNF Change as a Function of Age
GDNF has been found to exert neurotrophic effects in
many different peripheral and central models (Buj-Bello et
al., 1995; Henderson, 1996; Trupp et al., 1995). These
actions of GDNF frequently change as a function of devel-
opmental age (Buj-Bello et al., 1995). The development of
specific types of neuron may thus be affected differently by
GDNF at different ages. In the current studies, of postmi-
gratory enteric crest-derived cells, two qualitatively differ-
ent kinds of action of GDNF were found, a mitogenic effect
on unspecified precursors at E12 and a neurotrophic effect
FIG. 14. GFRa-2 immunoreactivity is exhibited by relatively rare
small clusters of neurons in cultures of crest-derived cells immu-
noselected from the fetal rat gut at E12 with antibodies to p75NTR.
(A) Culture immunostained with antibodies to GFRa-2. In addition
to the cell bodies, relatively thick bundles of neurites (arrow) are
immunostained. (B) Culture immunostained with preimmune se-
rum. No cells or neurites are stained, but unstained neuritic
processes (arrow) can be discerned. Calibration bars, 25 mm.
FIG. 13. GDNF increases the proportion of cells that express
GFRa-1 immunoreactivity in cultures of crest-derived cells immu-
noselected at E12 with antibodies to p75NTR. Almost no increase
by GDNF in GFRa-1 immunoreactivity can be seen in cultures of
residual cells.
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at E14–16. The neurotrophic effect of GDNF, moreover,
was different from those of NT-3 or neuropoietic cytokines
(Chalazonitis et al., 1998) in that only GDNF altered the
ratio of neurons/glia in favor of neurons. These observa-
tions are consistent with at least three alternative possibili-
ties. (i) An early common neuron/glia precursor, which is
present at E12, could be replaced at E14 by specified neural
and glial precursors; GDNF might be able to maintain the
neural precursors while the glial precursors might require
other factors, such as neuregulins (Shah et al., 1994) which
might be supplied by the neurons. Enteric glia, for example,
are selectively lost in mice with targeted mutations in the
ErbB3 neuregulin receptor (Riethmacher et al., 1997). In the
fetal and adult human bowel, moreover, only neurons, and
not glia, express RET (Ba¨r et al., 1997). (ii) GDNF could
exert an instructive effect at E14-E16 on a retained neuron/
glia precursor to follow a neuronal lineage. (iii) Finally,
GDNF might promote the generation of a set of specified
glial precursors, which die in the absence of a required
factor. The observations that cells immunoselected at E14.5
from the fetal mouse gut with antibodies to Ret give rise in
clonal cultures to neurons, but not to glia, and that the
Ret-immunoreactive cells do not respond to glial growth
factor, support the concept that distinct populations of
Ret-expressing neuronal and non-Ret-expressing glial pro-
genitors become specified in the fetal bowel (Lo and Ander-
son, 1995). GDNF has been reported to promote glial
expression when applied to mixed cultures of crest- and
non-crest-derived cells from the gut (Heuckeroth et al.,
1998). GDNF, however, was found in the same study to fail
FIG. 15. GFRa immunoreactivity is detectable by immunocytochemistry in the fetal rat bowel at E13 and persists into adult life. (A) Cross
section through a loop of E13 fetal intestine and immunostained with antibodies to GFRa-1. Note the immunostained cluster of neurons
(arrow). M, mucosa. (B) Adjacent section through the same loop of E13 fetal intestine illustrated in A, but incubated with preimmune
serum. There is no staining. (C) E13 dorsal root ganglion. A subset of neurons exhibits GFRa-1 immunoreactivity. (D) Developing muscle
of the body wall. Nerve processes exhibit GFRa-1 immunoreactivity (arrow). (E and F) Adult rat intestine. Many neurons in both
submucosal (arrowhead) and myenteric ganglia (arrow) exhibit GFRa-1 immunoreactivity. CM, circular layer of smooth muscle.
Calibration bars, 25 mm.
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to promote the proliferation of glia. GDNF thus appears not
to affect cells in the glial lineage directly. It seems likely
that the glial effects of GDNF in the mixed cultures are
secondary to its primary action on neurons, which stimu-
late nonneuronal cells to secrete glial growth factors, such
as neuregulins (Riethmacher et al., 1997). Neuregulins
promote glial expression (Shah et al., 1994) and are pro-
duced by mesenchymal cells (Burden and Yarden, 1997).
Separation of Crest-Derived and Non-Crest-
Derived Cells
Crest-derived cells were isolated from the fetal bowel at
different ages to be able to examine the interaction of
GDNF with these cells, independently of any effects GDNF
might exert on other cells of the gut wall, or effects that
nonneuronal cells might exert on the precursors from the
neural crest. Since GDNF (Moore et al., 1996; Suvanto et
al., 1996; Treanor et al., 1996) and GFRa-1 (current study;
see also below) are expressed by non-crest-derived cells of
the enteric mesenchyme, it is particularly important to be
able to isolate the crest-derived cells in order to investigate
direct effects of GDNF. Cellular interactions might con-
found the interpretation of results obtained in studies of
explants of whole gut or dissociated mixed populations of
cells. An important feature of the design of the current
experiments, therefore, was that immunoselection was
employed to obtain relatively pure populations of crest- and
non-crest-derived cells.
Immunoselection has been utilized in earlier studies of
the development of enteric neurons (Chalazonitis et al.,
1994, 1997b, 1998; Lo and Anderson, 1995; Lo et al., 1997;
Pomeranz et al., 1993). Four crest-derived cell markers have
been employed in these studies, NC-1/HNK-1 immunore-
activity (Chalazonitis et al., 1994; Hearn et al., 1998;
Pomeranz et al., 1993), a laminin-binding protein (LBP110)
(Chalazonitis et al., 1997b), Ret (Lo and Anderson, 1995; Lo
et al., 1997), and p75NTR (Chalazonitis et al., 1997b, 1998).
In the earlier experiments, antibodies to p75NTR were
shown to select crest-derived cells specifically and effi-
ciently with very little contamination of the immunos-
elected population by cells that are not of neural crest
origin. Neurons and glia developed in the cultures of
immunoselected but not of residual cells. A broader popu-
lation of crest-derived precursors has been found to be
immunoselected with antibodies to p75NTR than to Ret (Lo
and Anderson, 1995). The Ret-immunoselected population
appears to be skewed toward neuronal precursors, and
specifically toward the relatively small subset that ex-
presses mash-1. These neurons, which are transiently cat-
echolaminergic and born early, account for no more than a
third of the neurons of the ENS (Blaugrund et al., 1996).
Since there are multiple lineages of enteric neuronal pre-
cursors, it is advantageous to immunoselect with p75NTR to
avoid biasing observations to a restricted set of precursors.
In the current experiments, the efficiency of p75NTR immu-
noselection was demonstrated to be independent of fetal
age, although more cells could be obtained from the bowel
of older fetuses (see Fig. 1). In contrast to the immuno-
selected population, the residual population contained al-
most no p75NTR-immunoreactive cells or mRNA encoding
NF-M. In the absence of GDNF, moreover, almost no
peripherin- or GFRa-1-immunoreactive cells developed in
residual cultures.
GFRa-1 Is Expressed in the Gut by both Crest- and
Non-Crest-Derived Cells
For early crest-derived neuronal precursors to be re-
sponsive to GDNF, they would have to exhibit both of
the components of the GDNF receptor complex, Ret and
GFRa-1. Ret is an integral membrane protein and would
thus have to be synthesized by the cells themselves;
however, since GFRa-1 is a peripheral glycosyl-
phosphoinositol-anchored protein (Buj-Bello et al., 1997;
Creedon et al., 1997; Jing et al., 1996; Klein et al., 1997;
Yu et al., 1998), the enteric crest-derived cells could
either synthesize their own GFRa-1 (an interaction in cis)
or obtain it from neighboring cells (an interaction in
trans) (Yu et al., 1998). Neurons have been demonstrated
to obtain GFRa-1 in either of these fashions; in fact,
targets can provide GFRa-1 to neurons that innervate
them (Yu et al., 1998). Previous studies have established
that enteric crest-derived cells express Ret (Pachnis et al.,
1993; Schuchardt et al., 1994; Tsuzuki et al., 1995) and
that the fetal gut contains mRNA-encoding GFRa-1
(Treanor et al., 1996; Widenfalk et al., 1997; Yu et al.,
1998). Prior studies have not established which cells of
the fetal bowel express and/or anchor GFRa-1. We now
find that mRNA-encoding GFRa-1 is expressed both by
the p75NTR-immunoselected and residual populations of
cells obtained from the fetal bowel. Both crest- and
non-crest-derived cells thus appear to be able to synthe-
size GFRa-1. On the other hand, in contrast to the
mRNA-encoding GFRa-1, GFRa-1 protein could only be
immunocytochemically demonstrated on crest-derived
cells. We detected GFRa-1 immunoreactivity in the E13
fetal bowel in situ, where it appeared in small clusters of
developing neurons. GFRa-1 persisted in enteric neurons
of both plexuses through adulthood. These observations
suggest that while both enteric crest-derived and non-
crest-derived cells synthesize GFRa-1, only crest-derived
cells in a neuronal lineage are able to anchor the protein
to their membranes.
Since Ret expression in the fetal gut is restricted to
crest-derived cells, which also appear to be the only cells of
the bowel wall that are capable of anchoring GFRa-1, the
effects of GDNF would be expected to be limited to crest-
derived cells, as indeed they were. It was not necessary,
however, to add exogenous GFRa-1 or medium from non-
crest-derived cells to a purified population of crest-derived
cells to detect either the mitogenic or the neurotrophic
effects of GDNF. The GFRa-1 synthesized by crest-derived
cells, therefore, must be sufficient to mediate the action of
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GDNF. This observation provides evidence that GDNF can
stimulate enteric crest-derived cells through an interaction
in cis. Since non-crest-derived cells synthesize GFRa-1, but
do not anchor it in quantities adequate for its immunocy-
tochemical demonstration, these cells probably secrete
GFRa-1. It thus seems likely that GFRa-1 interacts with
crest-derived cells in trans, as well as in cis; however, direct
evidence for an interaction in trans was not obtained. If an
interaction with GFRa-1 in cis is sufficient for the activa-
tion of Ret by GDNF, the question arises as to why the
non-crest-derived cells should synthesize and presumably
secrete GFRa-1. One possible explanation is that an inter-
action of GFRa-1 in trans may amplify the effects of GDNF,
serving in situ to enhance its efficacy. The observation that
crest-derived precursors can interact with GFRa-1 in cis
when exogenous GDNF is presented to them experimen-
tally in supramaximal quantities does not necessarily mean
that an interaction in cis is sufficient for the optimal
stimulation of neuronal precursors by GDNF in situ.
GDNF, as well as GFRa-1, is also secreted in the fetal gut by
non-crest-derived cells (Moore et al., 1996; Suvanto et al.,
1996; Treanor et al., 1996); therefore, it is possible that the
binding of GDNF by GFRa-1 released by nonneuronal cells
protects endogenous GDNF and helps it to reach the Ret on
the surfaces of neuronal precursors. It is possible that the
synthesis and secretion of GFRa-1 by the non-crest-derived
cells of the bowel wall prior to the formation of neurons
creates an environment that is favorable for the critical
proliferative action of GDNF on the early crest-derived
e´migre´s that colonize the gut.
GDNF has previously been shown to promote the devel-
opment of neurons in primary cultures of mouse trunk
neural crest cells (Maxwell et al., 1996). In this case, GDNF
was found to enhance the development of neurons with an
adrenergic phenotype. The effect of GDNF on the primary
truncal crest cells was mimicked by NT-3 and dependent
on the presence in the cultures of serum and chick embryo
extract. In contrast to these primary crest cells, the effects
of GDNF on the postmigratory enteric crest-derived cells of
the current study were manifest in serum-free media and
did not require the presence of chick embryo extract. It is
possible that cultured primary crest cells do not express
GFRa-1. If so, then GDNF might be unable to affect these
cells unless they are cultured in complex GFRa-1-
containing media that interacts in trans with Ret-
expressing crest cells. HNK-1-immunoselected cells from
the developing avian gut have been found to respond to
GDNF in serum-free defined media, but only when they are
plated at high density (Hearn et al., 1998). Selected cells
that are plated at high density would be expected to contain
larger numbers of contaminating non-crest-derived cells,
which could be a source of GFRa-1 to interact in trans with
the crest-derived cell population. The ability of HNK-1-
immunoselected cells from the avian bowel to express
GFRa-1 has not been reported.
The number of GFRa-1-immunoreactive cells in cultures
was found in the current study to be greatly increased by
exposure to GDNF, an effect that could be explained by an
ability of GDNF to enhance the expression of its own
receptor (C. Iban˜ez, personal communication). Alterna-
tively, the GDNF-induced increase in GFRa-1-
immunoreactive cells may simply reflect the enhanced
development in the presence of GDNF of neurons, which
are the cells that anchor GFRa-1. Many fewer GFRa-2- than
GFRa-1-immunoreactive cells were found in cultured
populations of enteric cells, although GFRa-2 immunore-
activity, like that of GFRa-1, was largely restricted to the
crest-derived set of cells and GDNF increased the propor-
tion of cells displaying GFRa-2 immunoreactivity. Since
GFRa-1 appears to be the preferred receptor for GDNF,
while GFRa-2 is the preferred receptor for neurturin (Baloh
et al., 1997; Jing et al., 1997), these observations suggest
that GDNF probably plays a larger role than neurturin in
the development of the ENS. This conclusion is consistent
with the observations made with knockout mice showing
that the bowel is totally aganglionic distal to the rostral
foregut when GDNF is deficient (Moore et al., 1996; Pichel
et al., 1996), but relatively normal when neurturin is absent
(J. Milbrandt and R. O Heuckeroth, personal communica-
tion). Since neurturin is expressed in the fetal gut (Widen-
falk et al., 1997) and small numbers of cells were found to
express GFRa-2, it is possible that neurturin promotes the
development and/or survival of a minor subset of enteric
neurons. The loss of a small population of neurturin-
dependent cells from the ENS would probably be noticed in
studies of knockout animals only if the identity of such
cells were known so that they could be looked for specifi-
cally.
CONCLUSIONS
The observations made in this and prior studies are
consistent with the following heuristic model for the
formation of the ENS (Fig. 16). We propose that the
bowel, distal to the rostral foregut, is colonized by a
population of vagal and sacral crest-derived precursors, at
least some of which are pluripotent (Rothman et al.,
1990, 1993b; Sextier-Sainte-Claire Deville et al., 1994)
(Fig. 16, step 1). All of these precursors are GDNF-
dependent and thus presumably also express Ret and
anchor GFRa-1. Knockout of GDNF (Moore et al., 1996;
Pichel et al., 1996; Se´nchez et al., 1996) or Ret (Durbec et
al., 1996; Schuchardt et al., 1994) thus causes the bowel
to be totally aganglionic in the distributions of vagal and
sacral crest-derived e´migre´s (Durbec et al., 1996; Schu-
chardt et al., 1994). At the early stage, from the time the
crest-derived precursor cells enter the rat bowel at E9.5
(Baetge and Gershon, 1989; Baetge et al., 1990a,b)
through E12 (Fig. 16, step 2), GDNF stimulates prolifera-
tion and expands the number of precursor cells suffi-
ciently to build up a population large enough to com-
pletely colonize the bowel. We propose that at least some
of the progenitors that GDNF stimulates to divide are
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nestin-immunoreactive and are capable of giving rise to
neurons and/or glia. Between E12 and E14, the precursor
cells that proliferate in response to GDNF are replaced by
separate lineages of neuronal and glial progenitors (Fig.
16, step 3). The specified progenitors lose nestin, which is
replaced by type-specific cytosolic and intermediate fila-
ment proteins. Cells in the neuronal lineage express PGP
9.5 and peripherin or NF proteins. Cells in the glial
lineage first express S-100, and later also express glial
fibrillary acidic protein (GFAP). GDNF exerts a neurotro-
phic effect and maintains cells in the neuronal lineage,
but does not promote the development of glia. We pro-
pose that glial development must be maintained by a
factor that was not present in the defined medium used in
the present experiments. Since enteric glia are lost in
ErbB3 knockout mice (Riethmacher et al., 1997), it is
possible that the factor required for glial development is
a neuregulin, such as glial growth factor (Shah et al.,
1994). In contrast to GDNF, glial development can be
promoted by NT-3 and a neuropoietic cytokine (Chala-
zonitis et al., 1994, 1998). The mature ENS contains
many subsets of enteric neurons. This phenotypic diver-
sity arises as the result of complex interactions (which
predominantly occur after E14) between multiple lin-
eages of neurally specified progenitors and many different
growth factors and extracellular matrix molecules (Fig.
16, steps 4 –5). The growth factors may be provided by
crest- or non-crest-derived cells. In contrast to GDNF,
FIG. 16. Heuristic model providing a hypothesis describing the actions of GDNF, NT-3, and other factors (italics) on the development
of enteric neurons and glia (see text). A time line is shown at the left and stages in the differentiation of crest-derived precursors are
shown at the right. At step 1, the survival of enteric crest-derived cells is presumed to be GDNF-dependent. In the absence of GDNF,
Ret, or GFRa-1, therefore, no cells will develop at all in the vagal and sacral lineages of enteric neurons or glia. At step 2, GDNF
stimulates the proliferation of precursor cells. At step 3, GDNF supports the development of neurons, but not glia. This action may
include promotion of the expression of receptors such as TrkC, which enable enteric neuronal progenitors to respond to later-acting
growth factors, such as NT-3. At step 4, later-acting growth factors, including NT-3 and a neuropoietic cytokine, stimulate the
development of limited subsets of crest-derived cells. Some later-acting factors (NT-3, neuregulins) are able to promote glial
development.
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which affects the whole ENS, later-acting growth factors,
such as NT-3 (Chalazonitis et al., 1994) or a neuropoietic
cytokine (Chalazonitis et al., 1998), affect distinct sub-
sets of neurons.
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